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Background: Hypertension and dyslipidemia are major risk factors for cardiovascular  disease, 
accounting for the highest morbidity and mortality among the Bangladeshi  population. The 
objective of this study was to determine the association between serum lipid profiles in hyper-
tensive patients with normotensive control subjects in Bangladesh.
Methods: A cross-sectional study was carried out among 234 participants including 
159 hypertensive patients and 75 normotensive controls from January to December 2012 in the 
National Centre for Control of Rheumatic Fever and Heart Disease in Dhaka, Bangladesh. Data 
were collected on sociodemographic factors, anthropometric measurements, blood pressure, and 
lipid profile including total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL), 
and high density lipoprotein (HDL).
Results: The mean (± standard deviation) systolic blood pressure and diastolic blood pres-
sure of the participants were 137.94±9.58 and 94.42±8.81, respectively, which were higher 
in the hypertensive patients (P,0.001). The serum levels of TC, TG, and LDL were higher 
while HDL levels were lower in hypertensive subjects compared to normotensives, which was 
statistically significant (P,0.001). Age, waist circumference, and body mass index showed 
significant association with hypertensive patients (P,0.001) but not with normotensives. The 
logistic regression analysis showed that hypertensive patients had 1.1 times higher TC and TG, 
1.2 times higher LDL, and 1.1 times lower HDL than normotensives, which was statistically 
significant (P,0.05).
Conclusion: Hypertensive patients in Bangladesh have a close association with dyslipidemia 
and need measurement of blood pressure and lipid profile at regular intervals to prevent car-
diovascular disease, stroke, and other comorbidities.
Keywords: Risk factors, cardiovascular diseases, dyslipidemia, blood pressure
Introduction
Hypertension and dyslipidemia are major risk factors for cardiovascular disease 
(CVD) and account for more than 80% of deaths and disability in low- and middle-
income countries.1,2 The prevalence of hypertension is projected to increase globally, 
especially in the developing countries.2 In recent years, rapid urbanization, increased 
life expectancy, unhealthy diet, and lifestyle changes have led to an increased rate 
of CVD in Southeast Asia, including Bangladesh.3 It is widely accepted that CVD is 
associated with hypertension and increased blood levels of low-density lipoprotein 
(LDL), total cholesterol (TC), and triglycerides (TG). In contrast, a low level of high 
density lipoprotein (HDL) is a risk factor for mortality from CVD.4 Epidemiological 
studies have established a strong association between hypertension and coronary 
artery disease.5
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The noncommunicable disease risk factor survey con-
ducted in 2010 in Bangladesh estimated the prevalence of 
hypertension among adults to be from 16% to 20%.6 The 
Bangladesh Health, Nutrition and Demographic Survey in 
2011 found the prevalence of hypertension among adults to 
be 34%.7,8 A meta-analysis of the prevalence of hyperten-
sion in Bangladesh from 1995 to 2009 among 6,430 adults 
was estimated to be 13.5%, with a 95% confidence interval 
(CI) ranging from 12.7% to 14.2%.6 Another meta-analysis 
of prevalence of CVD and type 2 diabetes between 1995 
and 2010 found the pooled prevalence of hypertension to 
be 13.7% (12.1%–15.3%), with an increasing trend and 
higher rate in urban areas versus rural (22.2% versus 14.3%, 
respectively).9 However, these numbers are estimated from 
several studies and are likely not to account for silent and 
other asymptomatic CVD and hypertension.
CVD is the leading cause of disability and death worldwide, 
and a great majority of CVDs are associated with dyslipidemia. 
Worldwide, there is broad variation in serum lipid profile levels 
among different population groups. Increased serum levels of 
TC, TG, LDL, and decreased HDL are known to be associated 
with major risk factors for CVD. Dyslipidemia, comprising 
altered ratio of high TC level and isolated evaluation of the 
LDL or TG, is usually associated with increased blood pressure 
(BP) levels. There is a strong relationship between total LDL 
cholesterol concentrations and CVD risk. Patterns of lipid 
abnormalities among Asians and their relative impact on 
cardiovascular risk have not been well characterized.10 Low 
HDL is increasingly recognized as an independent risk factor 
for adverse CVD outcomes, irrespective of levels of LDL. 
Although sporadic reports suggest that the prevalence of low 
HDL-cholesterol is substantial, we lack detailed data on the 
true prevalence of this condition among patients receiving 
treatment for dyslipidemia.11 These data strongly suggest that 
low HDL is a clinically significant problem.
In Bangladesh, consumption of saturated fat and red meat 
is a known risk factor for CVD, especially hypertension.12 
However, data about the relationship between hypertension 
and lipid profile among Bangladeshi patients are rare in 
the literature. The purpose of the study was to compare the 
blood lipid levels in hypertensive patients with normoten-
sive control subjects and determine its association between 
hypertension and lipid profile.
Materials and methods
study design and population
A cross sectional study was conducted among 234 participants, 
159 newly diagnosed hypertensive patients and 75  participants 
with normal BP (normotensives), attending the National 
Centre for Control of Rheumatic Fever and Heart Disease 
(NCCRF&HD) in Dhaka, Bangladesh for a routine health 
check-up between January and December 2012. All the partici-
pants were residents of surrounding areas in Dhaka and aged 
between 30–60 years. Participants were selected consecutively 
from the outpatient department by the attending physician. 
Patients with features of any cardiac, renal, or hepatic compli-
cations or major medical problems were excluded. Also, those 
on lipid lowering and antihypertensive medication were also 
excluded. After obtaining oral and written informed consent, 
data was collected through face-to-face interviews, anthropo-
metric measurements, clinical examinations, and blood tests 
for serum lipid profile by trained research assistants.
Measurements
Height and body weight were measured with participants 
standing without shoes and heavy outer garments. Body mass 
index (BMI) was calculated as weight in kilograms, divided 
by height in meters squared (kg/m2). Waist circumference 
(WC) was measured from midway between the lowest rib 
and the iliac crest using a Gullick II tape with subjects in 
the standing position and at the end of a normal expiration. 
Two measurements were taken from each subject, and the 
mean value was used for the analysis. All anthropometric 
measurements were collected by the same individual.
BP was measured by a physician using standard BP mea-
surement protocol after the patient had rested for 10 minutes. 
Two measurements were taken by a mercury sphygmoma-
nometer, with at least a 5-minute interval between successive 
measurements. The mean of two measurements of Korotkoff 
phase I was recorded for systolic blood pressure (SBP). The 
mean of two values of Korotkoff phase IV was recorded for 
diastolic blood pressure (DBP). Hypertension was defined as 
an average SBP $140 mmHg and DBP $90 mmHg without 
antihypertensive medication according to the seventh report 
of the Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of High Blood Pressure (JNC-7).13 
In this study, hypertensive patients refer to those participants 
who demonstrated the JNC-7 criteria.
Biochemical analysis
A volume of 5 mL of venous blood was collected in the 
morning after an overnight fast, and serum was used for 
biochemical tests. All tests were carried out at the labora-
tory of the NCCRF&HD in Dhaka, Bangladesh. Lipid 
parameters (TC, TG, LDL, and HDL) were estimated by 
enzymatic colorimetric methods. Dyslipidemia was defined 
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according to the Evaluation and Treatment of High Blood 
Cholesterol in Adults executive summary of the third report 
of the National Cholesterol Education Program Expert Panel 
on Detection, Evaluation and Treatment of High Blood 
Cholesterol in Adults (Adult Treatment Panel III): LDL 
cholesterol (mg/dl) ,100= optimal, 100–129= near optimal/
above optimal, 130–159=borderline high, 160–189= high, 
$190= very high; total cholesterol (mg/dl) ,200= desirable, 
200–239= borderline high, $240= very high; HDL 
cholesterol (mg/dl) ,40=low, $60= high; triglyceride 
(mg/dl) ,150= normal (goal), 150–199= borderline high, 
200–499= high, $500=very high.14
ethics
Ethical clearance was obtained from the NCCRF&HD. 
Participants were informed about the study, and both verbal 
and written informed consent was obtained. The Helsinki 
Declaration was strictly followed for data collection.15
Data analysis
Data were analyzed using Statistical Package for Social 
 Sciences software, version 16.0 (SPSS Inc., Chicago, IL, 
USA). Descriptive statistics was used to present the demo-
graphic characteristics of the study participants. Continuous 
variables were presented as mean ± standard deviation (SD) 
and were compared using independent group Student’s t-tests. 
Binary logistic regression analysis was performed to measure 
the relationship of lipid profile among the hypertensive and 
normotensive patients after adjusting for age, BMI, sex, and 
BP. A P-value ,0.05 was considered statistically significant.
Results
The study included 234 participants with a mean age ± SD of 
44.7±5.7 years and BMI of 25.2±3.8 kg/m2. The mean SBP and 
DBP were 137.9±9.6 mmHg and 94.4±8.8 mmHg, respectively. 
The mean BMI, TC, HDL, and LDL were higher for males 
compared to females, which was statistically significant 
(P,0.05). The mean WC was higher in males, which was 
not statistically significant (P=0.051) (Table 1).
The mean age ± SD of hypertensive patients and nor-
motensives were 47.6±4.2 and 38.4±3.7 years,  respectively. 
Serum levels of TC, TG, and LDL were 238.3±3.4, 178.3±6.3, 
and 151.3±7.8 mg/dL, respectively, in hypertensive sub-
jects while in normotensive subjects, they were 187±6.2, 
141.5±11.2, and 110.3±6.3 mg/dL, respectively, which were 
significantly higher in hypertensive patients (P,0.001). The 
serum HDL was significantly lower (P,0.001) in hyperten-
sive patients (41.2±3.2 mg/dL) than in normotensive subjects 
(44.3±5.6 mg/dL). The mean SBPs of hypertensives and 
normotensives were 146.8±8.5 mmHg versus 119.2±9.3 
mmHg, respectively, and mean DBPs were 98.9±7.3 mmHg 
versus 84.9±5.3 mmHg, respectively. The mean SBP and 
DBP of hypertensives were higher than those of normoten-
sives (P,0.001). Age, WC, and BMI showed significant 
association with hypertensive patients (P,0.001) but not 
with normotensive subjects (Table 2).
Binary logistic regression analysis showed TC was 
significantly associated with hypertensive patients and the 
odds ratio (OR) was 1.1, 95% CI 0.91–1.77, P,0.002. TG 
and LDL were significantly associated with hypertensive 
patients (OR 1.1, 95% CI 0.49–1.44, P,0.05 and OR 
1.2, 95% CI 0.69–1.66, P,0.001, respectively). HDL was 
also associated with hypertensive patients (OR 1.08, 95% 
CI 0.77–1.52, P,0.05). DBP showed significant associa-
tion with hypertensive patients (OR 1.7, 95% CI 0.33–3.29, 
P,0.05) (Table 3).
Discussion
In this study, we investigated the relationship between serum 
lipid profile and hypertension among an urban population 
in Bangladesh. Results of this study revealed that the mean 
values of serum TC, TG, and LDL were significantly higher 
and statistically significant among the hypertensive patients 
compared to normotensives. The mean HDL level was lower 
in the hypertensives compared to normotensives and was 
statistically significant.
Hypertension is recognized globally as a major risk factor 
for CVD, stroke, diabetes, and renal diseases.16 About 80% 
of hypertensive persons have comorbidities such as obesity, 
glucose intolerance, abnormalities in lipid metabolism, 
among others. A prospective study in the northern region of 
Bangladesh comparing lipid profile status in hypertensive 
patients as compared to healthy normotensive controls found 
high serum TC, TG, and LDL, similar to our study.17 Our 
findings of increased levels of TC in hypertensive patients are 
similar to the findings of some other studies.16,18,19 However, 
few studies measured the strong association of hypertension 
and dyslipidemia among the Bangladeshi population.
Analysis from the INTERHEART study shows that among 
both cases and controls, mean LDL levels were about 10 mg/
dL lower in Asians compared with non-Asians.10 A greater 
proportion of Asian cases and controls had LDL #100 mg/
dL. HDL levels were slightly lower among Asians compared 
with non-Asians, a population who require further study and 
targeted intervention.10 Several studies have shown that most 
of the hypertensive patients undergo inconsistent treatment, 
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and there was significant instability of serum TC, TG, HDL, 
and LDL in hypertensive patients.19–21 Therefore, the find-
ings from investigations of these parameters may reinforce 
routine monitoring of hypertensive patients in daily clinical 
practice to prevent CVD and other harmful consequences 
of hypertension.22
A large scale study conducted in Mexico showed 
that the most prevalent abnormality in Mexican urban 
adults, aged 20–69 years, was HDL cholesterol below 
0.9 mmol/L (46.2% for men and 28.7% for women). 
Hypertriglyceridemia (.2.26 mmol/L) was the second 
most prevalent abnormality (24.3%). Increased LDL 
($4.21 mmol/L) was observed in 11.2% of the sample. 
Half of the  hypertriglyceridemic subjects had a mixed dys-
lipidemia or low HDL cholesterol. More than 50% of the 
low HDL cases were not related to hypertriglyceridemia.23 
The pan-European Survey of HDL measured lipids and 
other cardiovascular risk factors in 3,866 patients with 
type 2 diabetes and 4,436 nondiabetic patients under-
going treatment for dyslipidemia in eleven European 
Table 2 anthropometric and biochemical characteristics of participants
Indicators Hypertensive =159 Normotensive =75 P-value
Mean (SD) 95% CI Mean (SD) 95% CI
age (in years) 47.67 (4.15) 45.48–49.86 38.39 (3.69) 35.53–41.24 0.001
Height (meter) 1.55 (0.54) 1.53–1.57 1.66 (0.59) 1.34–1.73 0.001
Weight (kg) 62.32 (6.33) 60.41–64.23 56.87 (7.78) 54.09–59.65 0.001
Wc (cm) 86.01 (5.89) 84.25–87.76 78.27 (6.14) 75.40–81.13 0.001
BMi 25.98 (3.39) 25.10–26.85 23.58 (2.64) 22.58–24.59 0.001
sBP (mmHg) 146.77 (8.51) 141.11–151.42 119.21 (9.31) 117.42–23.01 0.001
DBP (mmHg) 98.92 (7.26) 94.49–101.36 84.89 (5.29) 81.17–87.61 0.001
Total cholesterol 238.31 (3.39) 221.01–242.5 187.01 (6.25) 181.52–191.51 0.001
Triglyceride 178.34 (6.31) 171.51–181.1 141.48 (11.29) 138.82–143.13 0.001
HDl 41.24 (3.22) 39.13–46.35 44.28 (5.63) 42.65–49.91 0.001
lDl 151.28 (7.77) 148.23–155.3 110.31 (6.34) 107.65–114.96 0.001
Male n (%) 113 (71) 32 (42) 0.002*
smoking n (%) 57 (36) 16 (21) 0.258*
Note: *Represents proportion test.
Abbreviations: BMI, body mass index; CI, confidence interval; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic 
blood pressure; sD, standard deviation; Wc, waist circumference.
Table 3 Binary logistic regression analysis for hypertensive and 
normotensive participants
Indicators Odds  
ratio
Confidence 
interval
P-value
Total cholesterol (,200 mg/dl) 1.12 0.91–1.77 0.002
Triglyceride (,150 mg/dl) 1.13 0.49–1.44 0.048
HDl (60 mg/dl) 1.08 0.77–1.52 0.031
lDl (,100 mg/dl) 1.24 0.69–1.66 0.001
sex (male) 0.98 0.41–1.12 0.221
sBP (,140 mmHg) 1.17 0.78–2.11 0.054
DBP (,90 mmHg) 1.74 0.33–3.29 0.044
Abbreviations: DBP, diastolic blood pressure; HDl, high density lipoprotein; 
lDl, low density lipoprotein; sBP, systolic blood pressure.
Table 1 characteristics of the respondents
Indicators Total (n=234) 
mean (SD)
Ranges Male (n=128) 
mean (SD)
Female (n=106) 
mean (SD)
P-value
age (in years) 44.70 (5.71) (38–51) 46.21 (4.48) 43.19 (6.14) 0.278
Height (meter) 1.55 (0.58) (1–2.03) 1.49 (0.49) 1.61 (0.63) 0.061
education (in years) 7 (3.01) (0–12) 8 (2.99) 6 (3.26) 0.872
Weight (kg) 60.57 (7.21) (41–72) 69.21 (6.36) 51.93 (8.11) 0.074
Wc (cm) 83.53 (6.3) (64–91) 88.89 (5.55) 78.17 (6.35) 0.051
BMi 25.21 (3.81) (21–28) 25.88 (3.61) 24.54 (2.97) 0.022
sBP (mmHg) 137.94 (9.58) (107–153) 139.12 (11.23) 136.76 (10.22) 0.047
DBP (mmHg) 94.42 (8.81) (86–111) 92.14 (7.58) 96.7 (8.39) 0.012
Total cholesterol 221.87 (4.14) (211–229) 224 (4.85) 219.74 (3.94) 0.032
Triglyceride 166.53 (7.38) (152–174) 169.21 (6.58) 163.85 (6.97) 0.004
HDl 42.21 (3.68) (37–46) 46.21 (4.01) 38.21 (3.33) 0.001
lDl 138.15 (5.25) (131–144) 141.11 (4.69) 135.19 (3.74) 0.014
Abbreviations: BMi, body mass index; DBP, diastolic blood pressure; HDl, high density lipoprotein; lDl, low density lipoprotein; sBP, systolic blood pressure; sD, standard 
deviation; Wc, waist circumference.
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countries, and showed that diabetic patients had lower HDL 
(1.22±0.37 mmol/L versus 1.35±0.44 mmol/L, P,0.001) 
and higher TG (2.32±2.10 mmol/L versus 1.85±1.60 
mmol/L, P,0.001) than nondiabetic patients.24 More 
diabetic compared to nondiabetic patients had low HDL 
(45% versus 30%, respectively), high TG ($1.7 mmol/L; 
57% versus 42%, respectively), or both (32% versus 19%, 
respectively). HDL ,0.9 mmol/L was found in 18% of 
diabetic and 12% of nondiabetic subjects.24
Previous studies showed the high rate of CVD  mortality 
among South-East Asian compared to the rest of the world 
and that majority of CVD deaths occur below the age 
of 70.25–28 A wide range of risk factors for CVD has been 
studied in Bangladesh, but few studies have measured the 
association of CVD risk with hypertension and lipid pro-
file. A study in rural areas of Bangladesh reported that the 
prevalence of “high” TC concentration (.240 mg/dL or 
.6.2 mmol/L) in Bangladesh is about 17%, “high” LDL 
($160 mg/dL or $4.2 mmol/L) is about 2%, and “low” HDL 
(,40 mg/dL or ,1.04 mmol/L) is about 67%.29
limitations
Our study has several limitations. First, the sample size was 
obtained from an urban hospital and may not be representa-
tive of all hypertensive patients in Bangladesh. Second, our 
sample size was small, and the control group was selected 
purposively, not age and sex matched. In addition, we could 
not compare the effects of lipid profile variation due to diet, 
physical activity, medication, or other factors.
Conclusion
The results of this study demonstrate that patients with hyper-
tension are more likely than normotensive patients to exhibit 
dyslipidemia, including elevated TC, LDL, TG, and reduced 
HDL cholesterol levels. Our results suggest that elevated BP 
may predict certain disturbances in lipoprotein metabolism. 
This association will help to develop future strategies for 
preventing both hypertension and dyslipidemia through 
proper lifestyle changes or medical management or by the 
combination of both. Hypertensive patients need measure-
ment of BP and lipid profile at regular intervals throughout 
their primary health care to prevent CVD and stroke.
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